Abstract
Background/Aims: Thiazolidinediones (TZD) are a new class of oral antidiabetic drugs that have been shown to inhibit growth of some epithelial cancer cells. Although TZD were found to be ligands...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have